Clinical Trials Logo

Immune Deficiency Disease clinical trials

View clinical trials related to Immune Deficiency Disease.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04232085 Recruiting - Clinical trials for Primary Immune Deficiency Disorder

Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide

Start date: February 12, 2020
Phase: Phase 2
Study type: Interventional

This is a Phase II prospective trial to assess the rates of donor engraftment using reduced intensity conditioning (RIC) hematopoietic stem cell transplant (HSCT) and post-transplant cyclophosphamide (PTCy) for patients with primary immune deficiencies (PID), immune dysregulatory syndromes (IDS), and inherited bone marrow failure syndromes (IBMFS).

NCT ID: NCT02337595 Recruiting - Clinical trials for Leukemia, Myeloid, Acute

Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation

45RA_NEG_DLI
Start date: August 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The stud will evaluate whether infusions of CD45RA-depleted lymphocytes from the donor early post-transplant is a safe way to improve immunity to common infections in recipients of TCR-alpha/beta depleted hematopoietic stem cell grafts.